VEXRX
Price
$107.70
Change
+$0.84 (+0.79%)
Updated
Jul 3 closing price
Net Assets
19.41B
VVSGX
Price
$16.91
Change
+$0.17 (+1.02%)
Updated
Jul 3 closing price
Net Assets
597.07M
Interact to see
Advertisement

VEXRX vs VVSGX

Header iconVEXRX vs VVSGX Comparison
Open Charts VEXRX vs VVSGXBanner chart's image
Vanguard Explorer Adm
Price$107.70
Change+$0.84 (+0.79%)
VolumeN/A
Net Assets19.41B
VALIC Company I Small Cap Growth
Price$16.91
Change+$0.17 (+1.02%)
VolumeN/A
Net Assets597.07M
VEXRX vs VVSGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VEXRX vs. VVSGX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VEXRX is a Buy and VVSGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 19.4B vs. VVSGX (597M). VEXRX pays higher dividends than VVSGX: VEXRX (0.52) vs VVSGX (0.17). VEXRX was incepted earlier than VVSGX: VEXRX (24 years) vs VVSGX (27 years). VVSGX (0.92) is less costly to investors than VEXRX (0.33). VVSGX is a more actively managed with annual turnover of: 54.00 vs. VEXRX (35.00). VVSGX has a lower initial minimum investment than VEXRX: VVSGX (0) vs VEXRX (50000). VVSGX annual gain was more profitable for investors over the last year : 8.74 vs. VEXRX (1.81). VEXRX return over 5 years is better than : 13.79 vs. VVSGX (-5.88).
VEXRXVVSGXVEXRX / VVSGX
Total Expense Ratio0.330.8738%
Annual Report Gross Expense Ratio0.330.9236%
Fund Existence24 years27 years-
Gain YTD0.7964.32418%
Front LoadN/AN/A-
Min. Initial Investment500000-
Min. Initial Investment IRAN/AN/A-
Net Assets19.4B597M3,250%
Annual Yield % from dividends0.520.17302%
Returns for 1 year1.818.7421%
Returns for 3 years21.5820.67104%
Returns for 5 years13.79-5.88-235%
Returns for 10 years18.801.94970%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMVP1.190.09
+8.18%
PMV Pharmaceuticals
ENVA115.850.39
+0.34%
Enova International
FITBP24.520.02
+0.08%
Fifth Third Bancorp
BPMC128.20N/A
N/A
Blueprint Medicines Corp
NPCE10.39-0.03
-0.29%
Neuropace